1. Drake, B. G., Baker, J. D., Hoffman, S. J., Landau, D. & Voels, S. A. In Human Exploration of Mars Design Reference Architecture 5.0, Addendum #2 (ed Drake, B. G. & Watts, K. D.) 17–66 (NASA Johnson Space Center, Houston, 2014). https://www.nasa.gov/sites/default/files/files/NASA-SP-2009-566-ADD2.pdf.
2. Patel, Z. S. et al. Red risks for a journey to the red planet: the highest priority human health risks for a mission to Mars. NPJ Microgravity 6, 33 (2020).
3. Hanson, A. et al. A Model-Based Systems Engineering Approach to Exploration Medical System Development, IEEE, 2019).
4. Bajaj, S., Sakhuja, N. & Singla, D. Stability testing of pharmaceutical products. J. Appl. Pharm. Sci. 2012, 129–138 (2021).
5. Bokser, A. D. & O’Donnell, P. B. in Remington: Essentials of Pharmaceutics (ed Felton, L.) 37–49 (Pharmaceutical Press, London, 2013).